Neuilly-sur-Seine, France

Etienne-Emile Baulieu


Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Etienne-Emile Baulieu: Innovator in Neurodegenerative Disease Treatment

Introduction

Etienne-Emile Baulieu is a prominent inventor based in Neuilly-sur-Seine, France. He has made significant contributions to the field of neurobiology, particularly in the treatment of degenerative diseases of the nervous system. With a total of 4 patents to his name, Baulieu's work has the potential to impact many lives.

Latest Patents

Baulieu's latest patents include a method for treating a degenerative disease of the nervous system using 3-methoxy-pregnenolone or its derivatives. This invention focuses on enhancing retention of recognition memory and recovering recognition memory deficits through the use of 3β-methoxy-pregna-5-ene-20-one. Additionally, he has developed a method for treating traumatic brain injuries, which involves administering an effective quantity of 3β-methoxy-pregna-5-ene-20-one (3β-methoxy-PREG) to patients.

Career Highlights

Baulieu is currently associated with Mapreg, a company dedicated to advancing research in neurodegenerative diseases. His innovative approaches and research have positioned him as a key figure in the field.

Collaborations

Throughout his career, Baulieu has collaborated with notable colleagues, including Paul Robel and Esther Fellous. These partnerships have further enriched his research and contributions to the scientific community.

Conclusion

Etienne-Emile Baulieu's work in neurobiology and his innovative patents highlight his commitment to improving treatments for degenerative diseases. His contributions continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…